{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T22:53:15Z","timestamp":1767999195062,"version":"3.49.0"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T00:00:00Z","timestamp":1405987200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s00428-014-1608-4","type":"journal-article","created":{"date-parts":[[2014,7,21]],"date-time":"2014-07-21T12:36:32Z","timestamp":1405946192000},"page":"119-133","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":99,"title":["Telomerase promoter mutations in cancer: an emerging molecular biomarker?"],"prefix":"10.1007","volume":"465","author":[{"given":"Jo\u00e3o","family":"Vinagre","sequence":"first","affiliation":[]},{"given":"Vasco","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"Ricardo","family":"Celestino","sequence":"additional","affiliation":[]},{"given":"Marta","family":"Reis","sequence":"additional","affiliation":[]},{"given":"Helena","family":"P\u00f3pulo","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Boaventura","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"Melo","sequence":"additional","affiliation":[]},{"given":"Telmo","family":"Catarino","sequence":"additional","affiliation":[]},{"given":"Jorge","family":"Lima","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Manuel","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"Valdemar","family":"M\u00e1ximo","sequence":"additional","affiliation":[]},{"given":"Manuel","family":"Sobrinho-Sim\u00f5es","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Soares","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,7,22]]},"reference":[{"key":"1608_CR1","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.eururo.2013.08.052","volume":"65","author":"Y Allory","year":"2014","unstructured":"Allory Y, Beukers W, Sagrera A, Flandez M, Marques M, Marquez M, van der Keur KA, Dyrskjot L, Lurkin I, Vermeij M, Carrato A, Lloreta J, Lorente JA, Carrillo-de Santa Pau E, Masius RG, Kogevinas M, Steyerberg EW, van Tilborg AA, Abas C, Orntoft TF, Zuiverloon TC, Malats N, Zwarthoff EC, Real FX (2014) Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome. Eur Urol 65:360\u2013366. doi: 10.1016\/j.eururo.2013.08.052","journal-title":"Eur Urol"},{"key":"1608_CR2","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.canep.2013.02.010","volume":"37","author":"GM Anic","year":"2013","unstructured":"Anic GM, Sondak VK, Messina JL, Fenske NA, Zager JS, Cherpelis BS, Lee JH, Fulp WJ, Epling-Burnette PK, Park JY, Rollison DE (2013) Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma. Cancer Epidemiol 37:434\u2013439. doi: 10.1016\/j.canep.2013.02.010","journal-title":"Cancer Epidemiol"},{"key":"1608_CR3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00401-013-1141-6","volume":"126","author":"H Arita","year":"2013","unstructured":"Arita H, Narita Y, Fukushima S, Tateishi K, Matsushita Y, Yoshida A, Miyakita Y, Ohno M, Collins VP, Kawahara N, Shibui S, Ichimura K (2013) Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss. Acta Neuropathol 126:267\u2013276. doi: 10.1007\/s00401-013-1141-6","journal-title":"Acta Neuropathol"},{"key":"1608_CR4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1152\/physrev.00026.2007","volume":"88","author":"G Aubert","year":"2008","unstructured":"Aubert G, Lansdorp PM (2008) Telomeres and aging. Physiol Rev 88:557\u2013579. doi: 10.1152\/physrev.00026.2007","journal-title":"Physiol Rev"},{"key":"1608_CR5","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1038\/nprot.2006.263","volume":"1","author":"GM Baerlocher","year":"2006","unstructured":"Baerlocher GM, Vulto I, de Jong G, Lansdorp PM (2006) Flow cytometry and FISH to measure the average length of telomeres (flow FISH). Nat Protoc 1:2365\u20132376. doi: 10.1038\/nprot.2006.263","journal-title":"Nat Protoc"},{"key":"1608_CR6","doi-asserted-by":"crossref","first-page":"11306","DOI":"10.1073\/pnas.0510085103","volume":"103","author":"S Bagheri","year":"2006","unstructured":"Bagheri S, Nosrati M, Li S, Fong S, Torabian S, Rangel J, Moore DH, Federman S, Laposa RR, Baehner FL, Sagebiel RW, Cleaver JE, Haqq C, Debs RJ, Blackburn EH, Kashani-Sabet M (2006) Genes and pathways downstream of telomerase in melanoma metastasis. Proc Natl Acad Sci U S A 103:11306\u201311311. doi: 10.1073\/pnas.0510085103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1608_CR7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/ng1084","volume":"33","author":"DM Baird","year":"2003","unstructured":"Baird DM, Rowson J, Wynford-Thomas D, Kipling D (2003) Extensive allelic variation and ultrashort telomeres in senescent human cells. Nat Genet 33:203\u2013207. doi: 10.1038\/ng1084","journal-title":"Nat Genet"},{"key":"1608_CR8","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1158\/1055-9965.EPI-07-0152","volume":"16","author":"V Bataille","year":"2007","unstructured":"Bataille V, Kato BS, Falchi M, Gardner J, Kimura M, Lens M, Perks U, Valdes AM, Bennett DC, Aviv A, Spector TD (2007) Nevus size and number are associated with telomere length and represent potential markers of a decreased senescence in vivo. Cancer Epidemiol Biomarkers Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 16:1499\u20131502. doi: 10.1158\/1055-9965.EPI-07-0152","journal-title":"Cancer Epidemiol Biomarkers Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol"},{"key":"1608_CR9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/350569a0","volume":"350","author":"EH Blackburn","year":"1991","unstructured":"Blackburn EH (1991) Structure and function of telomeres. Nature 350:569\u2013573. doi: 10.1038\/350569a0","journal-title":"Nature"},{"key":"1608_CR10","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","volume":"155","author":"CW Brennan","year":"2013","unstructured":"Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SH, Beroukhim R, Bernard B, Wu CJ, Genovese G, Shmulevich I, Barnholtz-Sloan J, Zou L, Vegesna R, Shukla SA, Ciriello G, Yung WK, Zhang W, Sougnez C, Mikkelsen T, Aldape K, Bigner DD, Van Meir EG, Prados M, Sloan A, Black KL, Eschbacher J, Finocchiaro G, Friedman W, Andrews DW, Guha A, Iacocca M, O\u2019Neill BP, Foltz G, Myers J, Weisenberger DJ, Penny R, Kucherlapati R, Perou CM, Hayes DN, Gibbs R, Marra M, Mills GB, Lander E, Spellman P, Wilson R, Sander C, Weinstein J, Meyerson M, Gabriel S, Laird PW, Haussler D, Getz G, Chin L, Network TR (2013) The somatic genomic landscape of glioblastoma. Cell 155:462\u2013477. doi: 10.1016\/j.cell.2013.09.034","journal-title":"Cell"},{"key":"1608_CR11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1600-0625.2010.01242.x","volume":"20","author":"EM Buckingham","year":"2011","unstructured":"Buckingham EM, Klingelhutz AJ (2011) The role of telomeres in the ageing of human skin. Exp Dermatol 20:297\u2013302. doi: 10.1111\/j.1600-0625.2010.01242.x","journal-title":"Exp Dermatol"},{"key":"1608_CR12","doi-asserted-by":"crossref","first-page":"e71121","DOI":"10.1371\/journal.pone.0071121","volume":"8","author":"LS Burke","year":"2013","unstructured":"Burke LS, Hyland PL, Pfeiffer RM, Prescott J, Wheeler W, Mirabello L, Savage SA, Burdette L, Yeager M, Chanock S, De Vivo I, Tucker MA, Goldstein AM, Yang XR (2013) Telomere length and the risk of cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations. PLoS One 8:e71121. doi: 10.1371\/journal.pone.0071121","journal-title":"PLoS One"},{"key":"1608_CR13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.mrfmmm.2011.07.006","volume":"730","author":"CM Buseman","year":"2012","unstructured":"Buseman CM, Wright WE, Shay JW (2012) Is telomerase a viable target in cancer? Mutat Res 730:90\u201397. doi: 10.1016\/j.mrfmmm.2011.07.006","journal-title":"Mutat Res"},{"key":"1608_CR14","doi-asserted-by":"crossref","first-page":"E1327","DOI":"10.1210\/jc.2011-2096","volume":"97","author":"S Cantara","year":"2012","unstructured":"Cantara S, Pisu M, Frau DV, Caria P, Dettori T, Capezzone M, Capuano S, Vanni R, Pacini F (2012) Telomere abnormalities and chromosome fragility in patients affected by familial papillary thyroid cancer. J Clin Endocrinol Metab 97:E1327\u2013E1331. doi: 10.1210\/jc.2011-2096","journal-title":"J Clin Endocrinol Metab"},{"key":"1608_CR15","doi-asserted-by":"crossref","first-page":"E1852","DOI":"10.1210\/jc.2011-1003","volume":"96","author":"M Capezzone","year":"2011","unstructured":"Capezzone M, Cantara S, Marchisotta S, Busonero G, Formichi C, Benigni M, Capuano S, Toti P, Pazaitou-Panayiotou K, Caruso G, Carli AF, Palummo N, Pacini F (2011) Telomere length in neoplastic and nonneoplastic tissues of patients with familial and sporadic papillary thyroid cancer. J Clin Endocrinol Metab 96:E1852\u2013E1856. doi: 10.1210\/jc.2011-1003","journal-title":"J Clin Endocrinol Metab"},{"key":"1608_CR16","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2174\/138920209789503897","volume":"10","author":"M Capezzone","year":"2009","unstructured":"Capezzone M, Marchisotta S, Cantara S, Pacini F (2009) Telomeres and thyroid cancer. Curr Genom 10:526\u2013533. doi: 10.2174\/138920209789503897","journal-title":"Curr Genom"},{"key":"1608_CR17","first-page":"528","volume":"2","author":"KA Carroll","year":"2009","unstructured":"Carroll KA, Ly H (2009) Telomere dysfunction in human diseases: the long and short of it! Int J Clin Exp Pathol 2:528\u2013543","journal-title":"Int J Clin Exp Pathol"},{"key":"1608_CR18","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.bjps.2006.01.022","volume":"59","author":"L Carvalho","year":"2006","unstructured":"Carvalho L, Lipay M, Belfort F, Santos I, Andrade J, Haddad A, Brunstein F, Ferreira L (2006) Telomerase activity in prognostic histopathologic features of melanoma. J Plast Reconstr Aesthet Surg JPRAS 59:961\u2013968. doi: 10.1016\/j.bjps.2006.01.022","journal-title":"J Plast Reconstr Aesthet Surg JPRAS"},{"key":"1608_CR19","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S1470-2045(13)70110-4","volume":"14","author":"P Castelo-Branco","year":"2013","unstructured":"Castelo-Branco P, Choufani S, Mack S, Gallagher D, Zhang C, Lipman T, Zhukova N, Walker EJ, Martin D, Merino D, Wasserman JD, Elizabeth C, Alon N, Zhang L, Hovestadt V, Kool M, Jones DT, Zadeh G, Croul S, Hawkins C, Hitzler J, Wang JC, Baruchel S, Dirks PB, Malkin D, Pfister S, Taylor MD, Weksberg R, Tabori U (2013) Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study. Lancet Oncol 14:534\u2013542. doi: 10.1016\/S1470-2045(13)70110-4","journal-title":"Lancet Oncol"},{"key":"1608_CR20","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/30.10.e47","volume":"30","author":"RM Cawthon","year":"2002","unstructured":"Cawthon RM (2002) Telomere measurement by quantitative PCR. Nucleic Acids Res 30:e47","journal-title":"Nucleic Acids Res"},{"key":"1608_CR21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrg2763","volume":"11","author":"AJ Cesare","year":"2010","unstructured":"Cesare AJ, Reddel RR (2010) Alternative lengthening of telomeres: models, mechanisms and implications. Nat Rev Genet 11:319\u2013330. doi: 10.1038\/nrg2763","journal-title":"Nat Rev Genet"},{"key":"1608_CR22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.mrfmmm.2011.10.003","volume":"730","author":"C Cifuentes-Rojas","year":"2012","unstructured":"Cifuentes-Rojas C, Shippen DE (2012) Telomerase regulation. Mutat Res 730:20\u201327. doi: 10.1016\/j.mrfmmm.2011.10.003","journal-title":"Mutat Res"},{"key":"1608_CR23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/8.1.137","volume":"8","author":"YS Cong","year":"1999","unstructured":"Cong YS, Wen J, Bacchetti S (1999) The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum Mol Genet 8:137\u2013142","journal-title":"Hum Mol Genet"},{"key":"1608_CR24","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1093\/emboj\/20.24.6958","volume":"20","author":"K Damm","year":"2001","unstructured":"Damm K, Hemmann U, Garin-Chesa P, Hauel N, Kauffmann I, Priepke H, Niestroj C, Daiber C, Enenkel B, Guilliard B, Lauritsch I, Muller E, Pascolo E, Sauter G, Pantic M, Martens UM, Wenz C, Lingner J, Kraut N, Rettig WJ, Schnapp A (2001) A highly selective telomerase inhibitor limiting human cancer cell proliferation. EMBO J 20:6958\u20136968. doi: 10.1093\/emboj\/20.24.6958","journal-title":"EMBO J"},{"key":"1608_CR25","author":"M Dono","year":"2014","unstructured":"Dono M, Angelini G, Cecconi M, Amaro A, Esposito AI, Mirisola V, Maric I, Lanza F, Nasciuti F, Viaggi S, Gualco M, Bandelloni R, Truini M, Coviello DA, Zupo S, Mosci C, Pfeffer U (2014) Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma. Br J Cancer. doi: 10.1038\/bjc.2013.804","journal-title":"Br J Cancer"},{"key":"1608_CR26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1182\/blood-2008-07-166421","volume":"113","author":"HY Du","year":"2009","unstructured":"Du HY, Pumbo E, Ivanovich J, An P, Maziarz RT, Reiss UM, Chirnomas D, Shimamura A, Vlachos A, Lipton JM, Goyal RK, Goldman F, Wilson DB, Mason PJ, Bessler M (2009) TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements. Blood 113:309\u2013316. doi: 10.1182\/blood-2008-07-166421","journal-title":"Blood"},{"key":"1608_CR27","author":"F Egberts","year":"2014","unstructured":"Egberts F, Kruger S, Behrens HM, Bergner I, Papaspyrou G, Werner JA, Alkatout I, Haag J, Hauschild A, Rocken C (2014) Melanomas of unknown primary frequently harbor TERT-promoter mutations. Melanoma Res. doi: 10.1097\/CMR.0000000000000048","journal-title":"Melanoma Res"},{"key":"1608_CR28","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1182\/blood-2003-12-4322","volume":"105","author":"H El-Daly","year":"2005","unstructured":"El-Daly H, Kull M, Zimmermann S, Pantic M, Waller CF, Martens UM (2005) Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532. Blood 105:1742\u20131749. doi: 10.1182\/blood-2003-12-4322","journal-title":"Blood"},{"key":"1608_CR29","unstructured":"Fabricius EVH, Raguse JR (2012) Molecular biology of basal cell carcinoma. In: Chapter 2, in Basal Cell Carcinoma, Madan, V (Ed.), published by InTech, Rijeka, Croatia, pp 19\u201354"},{"key":"1608_CR30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1523-1747.2000.00870.x","volume":"114","author":"M Folini","year":"2000","unstructured":"Folini M, Colella G, Villa R, Lualdi S, Daidone MG, Zaffaroni N (2000) Inhibition of telomerase activity by a hammerhead ribozyme targeting the RNA component of telomerase in human melanoma cells. J Investig Dermatol 114:259\u2013267. doi: 10.1046\/j.1523-1747.2000.00870.x","journal-title":"J Investig Dermatol"},{"key":"1608_CR31","doi-asserted-by":"crossref","first-page":"7406","DOI":"10.1093\/nar\/gkm644","volume":"35","author":"CK Garcia","year":"2007","unstructured":"Garcia CK, Wright WE, Shay JW (2007) Human diseases of telomerase dysfunction: insights into tissue aging. Nucleic Acids Res 35:7406\u20137416. doi: 10.1093\/nar\/gkm644","journal-title":"Nucleic Acids Res"},{"key":"1608_CR32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s004030050387","volume":"291","author":"A Glaessl","year":"1999","unstructured":"Glaessl A, Bosserhoff AK, Buettner R, Hohenleutner U, Landthaler M, Stolz W (1999) Increase in telomerase activity during progression of melanocytic cells from melanocytic naevi to malignant melanomas. Arch Dermatol Res 291:81\u201387","journal-title":"Arch Dermatol Res"},{"key":"1608_CR33","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/emboj\/20.11.2619","volume":"20","author":"E Gonzalez-Suarez","year":"2001","unstructured":"Gonzalez-Suarez E, Samper E, Ramirez A, Flores JM, Martin-Caballero J, Jorcano JL, Blasco MA (2001) Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J 20:2619\u20132630. doi: 10.1093\/emboj\/20.11.2619","journal-title":"EMBO J"},{"key":"1608_CR34","author":"S Goutagny","year":"2013","unstructured":"Goutagny S, Nault JC, Mallet M, Henin D, Rossi JZ, Kalamarides M (2013) High Incidence of activating tert promoter mutations in meningiomas undergoing malignant progression. Brain Pathol. doi: 10.1111\/bpa.12110","journal-title":"Brain Pathol"},{"key":"1608_CR35","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.trsl.2013.05.003","volume":"162","author":"MM Gramatges","year":"2013","unstructured":"Gramatges MM, Bertuch AA (2013) Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy. Transl Res J Lab Clin Med 162:353\u2013363. doi: 10.1016\/j.trsl.2013.05.003","journal-title":"Transl Res J Lab Clin Med"},{"key":"1608_CR36","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1128\/MCB.11.9.4572","volume":"11","author":"CW Greider","year":"1991","unstructured":"Greider CW (1991) Telomerase is processive. Mol Cell Biol 11:4572\u20134580","journal-title":"Mol Cell Biol"},{"key":"1608_CR37","doi-asserted-by":"crossref","first-page":"e80354","DOI":"10.1371\/journal.pone.0080354","volume":"8","author":"KG Griewank","year":"2013","unstructured":"Griewank KG, Murali R, Schilling B, Schimming T, Moller I, Moll I, Schwamborn M, Sucker A, Zimmer L, Schadendorf D, Hillen U (2013) TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma. PLoS One 8:e80354. doi: 10.1371\/journal.pone.0080354","journal-title":"PLoS One"},{"key":"1608_CR38","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/bjc.2013.312","volume":"109","author":"KG Griewank","year":"2013","unstructured":"Griewank KG, Murali R, Schilling B, Scholz S, Sucker A, Song M, Susskind D, Grabellus F, Zimmer L, Hillen U, Steuhl KP, Schadendorf D, Westekemper H, Zeschnigk M (2013) TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours. Br J Cancer 109:497\u2013501. doi: 10.1038\/bjc.2013.312","journal-title":"Br J Cancer"},{"key":"1608_CR39","author":"KG Griewank","year":"2013","unstructured":"Griewank KG, Schilling B, Murali R, Bielefeld N, Schwamborn M, Sucker A, Zimmer L, Hillen U, Schaller J, Brenn T, Schadendorf D, Mentzel T (2013) TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas. Mod Pathol Off J U S Can Acad Pathol Inc. doi: 10.1038\/modpathol.2013.168","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"1608_CR40","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJMra003200","volume":"345","author":"TJ Gross","year":"2001","unstructured":"Gross TJ, Hunninghake GW (2001) Idiopathic pulmonary fibrosis. N Engl J Med 345:517\u2013525. doi: 10.1056\/NEJMra003200","journal-title":"N Engl J Med"},{"key":"1608_CR41","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cell.2013.01.010","volume":"152","author":"C Gunes","year":"2013","unstructured":"Gunes C, Rudolph KL (2013) The role of telomeres in stem cells and cancer. Cell 152:390\u2013393. doi: 10.1016\/j.cell.2013.01.010","journal-title":"Cell"},{"key":"1608_CR42","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/jid.2008.238","volume":"129","author":"J Han","year":"2009","unstructured":"Han J, Qureshi AA, Prescott J, Guo Q, Ye L, Hunter DJ, De Vivo I (2009) A prospective study of telomere length and the risk of skin cancer. J Investig Dermatol 129:415\u2013421. doi: 10.1038\/jid.2008.238","journal-title":"J Investig Dermatol"},{"key":"1608_CR43","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1073\/pnas.93.13.6476","volume":"93","author":"C Harle-Bachor","year":"1996","unstructured":"Harle-Bachor C, Boukamp P (1996) Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci U S A 93:6476\u20136481","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1608_CR44","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0014-4827(61)90192-6","volume":"25","author":"L Hayflick","year":"1961","unstructured":"Hayflick L, Moorhead PS (1961) The serial cultivation of human diploid cell strains. Exp Cell Res 25:585\u2013621","journal-title":"Exp Cell Res"},{"key":"1608_CR45","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1126\/science.1207313","volume":"333","author":"CM Heaphy","year":"2011","unstructured":"Heaphy CM, de Wilde RF, Jiao Y, Klein AP, Edil BH, Shi C, Bettegowda C, Rodriguez FJ, Eberhart CG, Hebbar S, Offerhaus GJ, McLendon R, Rasheed BA, He Y, Yan H, Bigner DD, Oba-Shinjo SM, Marie SK, Riggins GJ, Kinzler KW, Vogelstein B, Hruban RH, Maitra A, Papadopoulos N, Meeker AK (2011) Altered telomeres in tumors with ATRX and DAXX mutations. Science 333:425. doi: 10.1126\/science.1207313","journal-title":"Science"},{"key":"1608_CR46","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.ajpath.2011.06.018","volume":"179","author":"CM Heaphy","year":"2011","unstructured":"Heaphy CM, Subhawong AP, Hong SM, Goggins MG, Montgomery EA, Gabrielson E, Netto GJ, Epstein JI, Lotan TL, Westra WH, Shih Ie M, Iacobuzio-Donahue CA, Maitra A, Li QK, Eberhart CG, Taube JM, Rakheja D, Kurman RJ, Wu TC, Roden RB, Argani P, De Marzo AM, Terracciano L, Torbenson M, Meeker AK (2011) Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. Am J Pathol 179:1608\u20131615. doi: 10.1016\/j.ajpath.2011.06.018","journal-title":"Am J Pathol"},{"key":"1608_CR47","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1038\/ncomms4401","volume":"5","author":"B Heidenreich","year":"2014","unstructured":"Heidenreich B, Nagore E, Rachakonda PS, Garcia-Casado Z, Requena C, Traves V, Becker J, Soufir N, Hemminki K, Kumar R (2014) Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma. Nat Commun 5:3401. doi: 10.1038\/ncomms4401","journal-title":"Nat Commun"},{"key":"1608_CR48","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1158\/1078-0432.217.11.1","volume":"11","author":"JD Henson","year":"2005","unstructured":"Henson JD, Hannay JA, McCarthy SW, Royds JA, Yeager TR, Robinson RA, Wharton SB, Jellinek DA, Arbuckle SM, Yoo J, Robinson BG, Learoyd DL, Stalley PD, Bonar SF, Yu D, Pollock RE, Reddel RR (2005) A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clin Cancer Res Off J Am Assoc Cancer Res 11:217\u2013225","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"1608_CR49","first-page":"2117","volume":"58","author":"S Hiraga","year":"1998","unstructured":"Hiraga S, Ohnishi T, Izumoto S, Miyahara E, Kanemura Y, Matsumura H, Arita N (1998) Telomerase activity and alterations in telomere length in human brain tumors. Cancer Res 58:2117\u20132125","journal-title":"Cancer Res"},{"key":"1608_CR50","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1230062","volume":"339","author":"S Horn","year":"2013","unstructured":"Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, Gast A, Kadel S, Moll I, Nagore E, Hemminki K, Schadendorf D, Kumar R (2013) TERT promoter mutations in familial and sporadic melanoma. Science 339:959\u2013961. doi: 10.1126\/science.1230062","journal-title":"Science"},{"key":"1608_CR51","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1651-2227.1988.tb10751.x","volume":"77","author":"S Hreidarsson","year":"1988","unstructured":"Hreidarsson S, Kristjansson K, Johannesson G, Johannsson JH (1988) A syndrome of progressive pancytopenia with microcephaly, cerebellar hypoplasia and growth failure. Acta Paediatr Scand 77:773\u2013775","journal-title":"Acta Paediatr Scand"},{"key":"1608_CR52","first-page":"593","volume":"101","author":"S Hu","year":"2002","unstructured":"Hu S, Chan HL, Chen MC, Pang JH (2002) Telomerase expression in benign and malignant skin neoplasms: comparison of three major subunits. J Formos Med Assoc Taiwan Yi Zhi 101:593\u2013597","journal-title":"J Formos Med Assoc Taiwan Yi Zhi"},{"key":"1608_CR53","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.1229259","volume":"339","author":"FW Huang","year":"2013","unstructured":"Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA (2013) Highly recurrent TERT promoter mutations in human melanoma. Science 339:957\u2013959. doi: 10.1126\/science.1229259","journal-title":"Science"},{"key":"1608_CR54","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.eururo.2013.08.057","volume":"65","author":"CD Hurst","year":"2014","unstructured":"Hurst CD, Platt FM, Knowles MA (2014) Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine. Eur Urol 65:367\u2013369. doi: 10.1016\/j.eururo.2013.08.057","journal-title":"Eur Urol"},{"key":"1608_CR55","doi-asserted-by":"crossref","first-page":"E1876","DOI":"10.1210\/jc.2011-1643","volume":"96","author":"J Jendrzejewski","year":"2011","unstructured":"Jendrzejewski J, Tomsic J, Lozanski G, Labanowska J, He H, Liyanarachchi S, Nagy R, Ringel MD, Kloos RT, Heerema NA, de la Chapelle A (2011) Telomere length and telomerase reverse transcriptase gene copy number in patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 96:E1876\u2013E1880. doi: 10.1210\/jc.2011-1643","journal-title":"J Clin Endocrinol Metab"},{"key":"1608_CR56","doi-asserted-by":"crossref","first-page":"709","DOI":"10.18632\/oncotarget.588","volume":"3","author":"Y Jiao","year":"2012","unstructured":"Jiao Y, Killela PJ, Reitman ZJ, Rasheed AB, Heaphy CM, de Wilde RF, Rodriguez FJ, Rosemberg S, Oba-Shinjo SM, Nagahashi Marie SK, Bettegowda C, Agrawal N, Lipp E, Pirozzi C, Lopez G, He Y, Friedman H, Friedman AH, Riggins GJ, Holdhoff M, Burger P, McLendon R, Bigner DD, Vogelstein B, Meeker AK, Kinzler KW, Papadopoulos N, Diaz LA, Yan H (2012) Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas. Oncotarget 3:709\u2013722","journal-title":"Oncotarget"},{"key":"1608_CR57","doi-asserted-by":"crossref","unstructured":"Killela PJ, Pirozzi CJ, Healy P, Reitman ZJ, Lipp E, Rasheed BA, Yang R, Diplas BH, Wang Z, Greer PK, Zhu H, Wang CY, Carpenter AB, Friedman H, Friedman AH, Keir ST, He J, He Y, McLendon RE, Herndon JE, 2nd, Yan H, Bigner DD (2014) Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas. Oncotarget 5:1515\u20131525","DOI":"10.18632\/oncotarget.1765"},{"key":"1608_CR58","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1073\/pnas.1303607110","volume":"110","author":"PJ Killela","year":"2013","unstructured":"Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz LA Jr, Friedman AH, Friedman H, Gallia GL, Giovanella BC, Grollman AP, He TC, He Y, Hruban RH, Jallo GI, Mandahl N, Meeker AK, Mertens F, Netto GJ, Rasheed BA, Riggins GJ, Rosenquist TA, Schiffman M, Shih Ie M, Theodorescu D, Torbenson MS, Velculescu VE, Wang TL, Wentzensen N, Wood LD, Zhang M, McLendon RE, Bigner DD, Kinzler KW, Vogelstein B, Papadopoulos N, Yan H (2013) TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci U S A 110:6021\u20136026. doi: 10.1073\/pnas.1303607110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1608_CR59","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1126\/science.7605428","volume":"266","author":"NW Kim","year":"1994","unstructured":"Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011\u20132015","journal-title":"Science"},{"key":"1608_CR60","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/nprot.2010.124","volume":"5","author":"M Kimura","year":"2010","unstructured":"Kimura M, Stone RC, Hunt SC, Skurnick J, Lu X, Cao X, Harley CB, Aviv A (2010) Measurement of telomere length by the Southern blot analysis of terminal restriction fragment lengths. Nat Protoc 5:1596\u20131607. doi: 10.1038\/nprot.2010.124","journal-title":"Nat Protoc"},{"key":"1608_CR61","doi-asserted-by":"crossref","first-page":"7162","DOI":"10.1158\/0008-5472.CAN-13-2498","volume":"73","author":"I Kinde","year":"2013","unstructured":"Kinde I, Munari E, Faraj SF, Hruban RH, Schoenberg M, Bivalacqua T, Allaf M, Springer S, Wang Y, Diaz LA Jr, Kinzler KW, Vogelstein B, Papadopoulos N, Netto GJ (2013) TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine. Cancer Res 73:7162\u20137167. doi: 10.1158\/0008-5472.CAN-13-2498","journal-title":"Cancer Res"},{"key":"1608_CR62","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1756-9966-33-33","volume":"33","author":"C Koelsche","year":"2014","unstructured":"Koelsche C, Renner M, Hartmann W, Brandt R, Lehner B, Waldburger N, Alldinger I, Schmitt T, Egerer G, Penzel R, Wardelmann E, Schirmacher P, von Deimling A, Mechtersheimer G (2014) TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities. J Exp Clin Cancer Res CR 33:33. doi: 10.1186\/1756-9966-33-33","journal-title":"J Exp Clin Cancer Res CR"},{"key":"1608_CR63","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00401-013-1195-5","volume":"126","author":"C Koelsche","year":"2013","unstructured":"Koelsche C, Sahm F, Capper D, Reuss D, Sturm D, Jones DT, Kool M, Northcott PA, Wiestler B, Bohmer K, Meyer J, Mawrin C, Hartmann C, Mittelbronn M, Platten M, Brokinkel B, Seiz M, Herold-Mende C, Unterberg A, Schittenhelm J, Weller M, Pfister S, Wick W, Korshunov A, von Deimling A (2013) Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system. Acta Neuropathol 126:907\u2013915. doi: 10.1007\/s00401-013-1195-5","journal-title":"Acta Neuropathol"},{"key":"1608_CR64","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3390\/s8010347","volume":"8","author":"E Kulla","year":"2008","unstructured":"Kulla E, Katz E (2008) Biosensor Techniques used for determination of telomerase activity in cancer cells. Sensors 8:347\u2013369","journal-title":"Sensors"},{"key":"1608_CR65","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/j.1349-7006.2008.00878.x","volume":"99","author":"S Kyo","year":"2008","unstructured":"Kyo S, Takakura M, Fujiwara T, Inoue M (2008) Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers. Cancer Sci 99:1528\u20131538. doi: 10.1111\/j.1349-7006.2008.00878.x","journal-title":"Cancer Sci"},{"key":"1608_CR66","doi-asserted-by":"crossref","first-page":"E1562","DOI":"10.1210\/jc.2013-2383","volume":"98","author":"I Landa","year":"2013","unstructured":"Landa I, Ganly I, Chan TA, Mitsutake N, Matsuse M, Ibrahimpasic T, Ghossein RA, Fagin JA (2013) Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease. J Clin Endocrinol Metab 98:E1562\u2013E1566. doi: 10.1210\/jc.2013-2383","journal-title":"J Clin Endocrinol Metab"},{"key":"1608_CR67","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(95)91865-5","volume":"346","author":"LA Langford","year":"1995","unstructured":"Langford LA, Piatyszek MA, Xu R, Schold SC Jr, Shay JW (1995) Telomerase activity in human brain tumours. Lancet 346:1267\u20131268","journal-title":"Lancet"},{"key":"1608_CR68","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1158\/1055-9965.EPI-11-0072","volume":"20","author":"G Liang","year":"2011","unstructured":"Liang G, Qureshi AA, Guo Q, De Vivo I, Han J (2011) No association between telomere length in peripheral blood leukocytes and the risk of nonmelanoma skin cancer. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 20:1043\u20131045. doi: 10.1158\/1055-9965.EPI-11-0072","journal-title":"Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol"},{"key":"1608_CR69","author":"JY Liau","year":"2014","unstructured":"Liau JY, Tsai JH, Jeng YM, Chu CY, Kuo KT, Liang CW (2014) TERT promoter mutation is uncommon in acral lentiginous melanoma. J Cutan Pathol. doi: 10.1111\/cup.12323","journal-title":"J Cutan Pathol"},{"key":"1608_CR70","first-page":"929","volume":"2","author":"Y Lin","year":"1996","unstructured":"Lin Y, Miyamoto H, Fujinami K, Uemura H, Hosaka M, Iwasaki Y, Kubota Y (1996) Telomerase activity in human bladder cancer. Clin Cancer Res Off J Am Assoc Cancer Res 2:929\u2013932","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"1608_CR71","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00401-013-1225-3","volume":"127","author":"JC Lindsey","year":"2014","unstructured":"Lindsey JC, Schwalbe EC, Potluri S, Bailey S, Williamson D, Clifford SC (2014) TERT promoter mutation and aberrant hypermethylation are associated with elevated expression in medulloblastoma and characterise the majority of non-infant SHH subgroup tumours. Acta Neuropathol 127:307\u2013309. doi: 10.1007\/s00401-013-1225-3","journal-title":"Acta Neuropathol"},{"key":"1608_CR72","first-page":"35","volume":"1805","author":"JP Liu","year":"2010","unstructured":"Liu JP, Chen W, Schwarer AP, Li H (2010) Telomerase in cancer immunotherapy. Biochim Biophys Acta 1805:35\u201342. doi: 10.1016\/j.bbcan.2009.09.001","journal-title":"Biochim Biophys Acta"},{"key":"1608_CR73","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.gene.2014.02.051","volume":"540","author":"T Liu","year":"2014","unstructured":"Liu T, Liang X, Bjorkholm M, Jia J, Xu D (2014) The absence of TERT promoter mutations in primary gastric cancer. Gene 540:266\u2013267. doi: 10.1016\/j.gene.2014.02.051","journal-title":"Gene"},{"key":"1608_CR74","author":"T Liu","year":"2013","unstructured":"Liu T, Wang N, Cao J, Sofiadis A, Dinets A, Zedenius J, Larsson C, Xu D (2013) The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas. Oncogene. doi: 10.1038\/onc.2013.446","journal-title":"Oncogene"},{"key":"1608_CR75","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1530\/ERC-13-0210","volume":"20","author":"X Liu","year":"2013","unstructured":"Liu X, Bishop J, Shan Y, Pai S, Liu D, Murugan AK, Sun H, El-Naggar AK, Xing M (2013) Highly prevalent TERT promoter mutations in aggressive thyroid cancers. Endocr Relat Cancer 20:603\u2013610. doi: 10.1530\/ERC-13-0210","journal-title":"Endocr Relat Cancer"},{"key":"1608_CR76","author":"X Liu","year":"2014","unstructured":"Liu X, Qu S, Liu R, Sheng C, Shi X, Zhu G, Murugan AK, Guan H, Yu H, Wang Y, Sun H, Shan Z, Teng W, Xing M (2014) TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer. J Clin Endocrinol Metab. doi: 10.1210\/jc.2013-4048","journal-title":"J Clin Endocrinol Metab"},{"key":"1608_CR77","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.4161\/cc.24662","volume":"12","author":"X Liu","year":"2013","unstructured":"Liu X, Wu G, Shan Y, Hartmann C, von Deimling A, Xing M (2013) Highly prevalent TERT promoter mutations in bladder cancer and glioblastoma. Cell Cycle 12:1637\u20131638. doi: 10.4161\/cc.24662","journal-title":"Cell Cycle"},{"key":"1608_CR78","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/neuonc\/nos329","volume":"15","author":"D Lotsch","year":"2013","unstructured":"Lotsch D, Ghanim B, Laaber M, Wurm G, Weis S, Lenz S, Webersinke G, Pichler J, Berger W, Spiegl-Kreinecker S (2013) Prognostic significance of telomerase-associated parameters in glioblastoma: effect of patient age. Neuro-Oncology 15:423\u2013432. doi: 10.1093\/neuonc\/nos329","journal-title":"Neuro-Oncology"},{"key":"1608_CR79","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.gde.2005.04.004","volume":"15","author":"A Marrone","year":"2005","unstructured":"Marrone A, Walne A, Dokal I (2005) Dyskeratosis congenita: telomerase, telomeres and anticipation. Curr Opin Genet Dev 15:249\u2013257. doi: 10.1016\/j.gde.2005.04.004","journal-title":"Curr Opin Genet Dev"},{"key":"1608_CR80","author":"M Melo","year":"2014","unstructured":"Melo M, Rocha AG, Vinagre J, Batista R, Peixoto J, Tavares C, Celestino R, Almeida A, Salgado C, Eloy C, Castro P, Prazeres H, Lima J, Amaro T, Lobo C, Martins MJ, Moura M, Cavaco B, Leite V, Cameselle-Teijeiro JM, Carrilho F, Cavalheiro M, Maximo V, Sobrinho-Simoes M, Soares P (2014) TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas. J Clin Endocrinol Metab. doi: 10.1210\/jc.2013-3734","journal-title":"J Clin Endocrinol Metab"},{"key":"1608_CR81","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1053\/hupa.2000.9779","volume":"31","author":"C Miracco","year":"2000","unstructured":"Miracco C, Pacenti L, Santopietro R, Laurini L, Biagioli M, Luzi P (2000) Evaluation of telomerase activity in cutaneous melanocytic proliferations. Hum Pathol 31:1018\u20131021. doi: 10.1053\/hupa.2000.9779","journal-title":"Hum Pathol"},{"key":"1608_CR82","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.molmed.2012.11.006","volume":"19","author":"S Mocellin","year":"2013","unstructured":"Mocellin S, Pooley KA, Nitti D (2013) Telomerase and the search for the end of cancer. Trends Mol Med 19:125\u2013133. doi: 10.1016\/j.molmed.2012.11.006","journal-title":"Trends Mol Med"},{"key":"1608_CR83","first-page":"483","volume":"30","author":"L Montanaro","year":"2008","unstructured":"Montanaro L, Calienni M, Ceccarelli C, Santini D, Taffurelli M, Pileri S, Trere D, Derenzini M (2008) Relationship between dyskerin expression and telomerase activity in human breast cancer. Cell Oncol Off J Int Soc Cell Oncol 30:483\u2013490","journal-title":"Cell Oncol Off J Int Soc Cell Oncol"},{"key":"1608_CR84","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3892\/etm_00000015","volume":"1","author":"A Morii","year":"2010","unstructured":"Morii A, Komiya A, Okumura A, Fuse H (2010) Telomerase activity in bladder cancer tissue. Exp Ther Med 1:85\u201388. doi: 10.3892\/etm_00000015","journal-title":"Exp Ther Med"},{"key":"1608_CR85","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.mrfmmm.2011.04.008","volume":"730","author":"JP Murnane","year":"2012","unstructured":"Murnane JP (2012) Telomere dysfunction and chromosome instability. Mutat Res 730:28\u201336. doi: 10.1016\/j.mrfmmm.2011.04.008","journal-title":"Mutat Res"},{"key":"1608_CR86","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1158\/0008-5472.CAN-11-1988","volume":"71","author":"H Nan","year":"2011","unstructured":"Nan H, Du M, De Vivo I, Manson JE, Liu S, McTiernan A, Curb JD, Lessin LS, Bonner MR, Guo Q, Qureshi AA, Hunter DJ, Han J (2011) Shorter telomeres associate with a reduced risk of melanoma development. Cancer Res 71:6758\u20136763. doi: 10.1158\/0008-5472.CAN-11-1988","journal-title":"Cancer Res"},{"key":"1608_CR87","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nrm3505","volume":"14","author":"J Nandakumar","year":"2013","unstructured":"Nandakumar J, Cech TR (2013) Finding the end: recruitment of telomerase to telomeres. Nat Rev Mol Cell Biol 14:69\u201382. doi: 10.1038\/nrm3505","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1608_CR88","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1038\/ncomms3218","volume":"4","author":"JC Nault","year":"2013","unstructured":"Nault JC, Mallet M, Pilati C, Calderaro J, Bioulac-Sage P, Laurent C, Laurent A, Cherqui D, Balabaud C, Zucman-Rossi J (2013) High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions. Nat Commun 4:2218. doi: 10.1038\/ncomms3218","journal-title":"Nat Commun"},{"key":"1608_CR89","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00401-013-1163-0","volume":"126","author":"N Nonoguchi","year":"2013","unstructured":"Nonoguchi N, Ohta T, Oh JE, Kim YH, Kleihues P, Ohgaki H (2013) TERT promoter mutations in primary and secondary glioblastomas. Acta Neuropathol 126:931\u2013937. doi: 10.1007\/s00401-013-1163-0","journal-title":"Acta Neuropathol"},{"key":"1608_CR90","first-page":"1082","volume":"11","author":"A Okumura","year":"2004","unstructured":"Okumura A, Mizuno I, Nagakawa O, Fuse H (2004) Telomerase activity is correlated with lower grade and lower stage bladder carcinomas. Int J Urol Off J Japan Urol Assoc 11:1082\u20131086. doi: 10.1111\/j.1442-2042.2004.00960.x","journal-title":"Int J Urol Off J Japan Urol Assoc"},{"key":"1608_CR91","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.bjc.6690010","volume":"79","author":"CN Parris","year":"1999","unstructured":"Parris CN, Jezzard S, Silver A, MacKie R, McGregor JM, Newbold RF (1999) Telomerase activity in melanoma and non-melanoma skin cancer. Br J Cancer 79:47\u201353. doi: 10.1038\/sj.bjc.6690010","journal-title":"Br J Cancer"},{"key":"1608_CR92","doi-asserted-by":"crossref","first-page":"15566","DOI":"10.1074\/jbc.M201266200","volume":"277","author":"E Pascolo","year":"2002","unstructured":"Pascolo E, Wenz C, Lingner J, Hauel N, Priepke H, Kauffmann I, Garin-Chesa P, Rettig WJ, Damm K, Schnapp A (2002) Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate. J Biol Chem 277:15566\u201315572. doi: 10.1074\/jbc.M201266200","journal-title":"J Biol Chem"},{"key":"1608_CR93","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.humpath.2007.11.008","volume":"39","author":"K Perrem","year":"2008","unstructured":"Perrem K, Lynch A, Al Nooh F, Leader M, Elaine K (2008) The different telomere lengths in basal and squamous cell carcinomas also differ between the nontransplant and renal transplant population. Hum Pathol 39:1034\u20131041. doi: 10.1016\/j.humpath.2007.11.008","journal-title":"Hum Pathol"},{"key":"1608_CR94","author":"H Populo","year":"2014","unstructured":"Populo H, Boaventura P, Vinagre J, Batista R, Mendes A, Caldas R, Pardal J, Azevedo F, Honavar M, Guimaraes I, Manuel Lopes J, Sobrinho-Simoes M, Soares P (2014) TERT Promoter mutations in skin cancer: the effects of sun exposure and X-irradiation. J Investig Dermatol. doi: 10.1038\/jid.2014.163","journal-title":"J Investig Dermatol"},{"key":"1608_CR95","first-page":"819","volume":"17","author":"A Preto","year":"2004","unstructured":"Preto A, Cameselle-Teijeiro J, Moldes-Boullosa J, Soares P, Cameselle-Teijeiro JF, Silva P, Reis-Filho JS, Reyes-Santias RM, Alfonsin-Barreiro N, Forteza J, Sobrinho-Simoes M (2004) Telomerase expression and proliferative activity suggest a stem cell role for thyroid solid cell nests. Mod Pathol Off J U S Can Acad Pathol Inc 17:819\u2013826. doi: 10.1038\/modpathol.3800124","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"1608_CR96","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jgm.669","volume":"7","author":"GJ Prud\u2019homme","year":"2005","unstructured":"Prud\u2019homme GJ (2005) DNA vaccination against tumors. J Gene Med 7:3\u201317. doi: 10.1002\/jgm.669","journal-title":"J Gene Med"},{"key":"1608_CR97","author":"Y Qu","year":"2014","unstructured":"Qu Y, Dang S, Wu K, Shao Y, Yang Q, Ji M, Shi B, Hou P (2014) TERT promoter mutations predict worse survival in laryngeal cancer patients. Int J Cancer. doi: 10.1002\/ijc.28728","journal-title":"Int J Cancer"},{"key":"1608_CR98","author":"Y Qu","year":"2013","unstructured":"Qu Y, Shi L, Wang D, Zhang B, Yang Q, Ji M, Shi B, Hou P (2013) Low frequency of TERT promoter mutations in a large cohort of gallbladder and gastric cancers. Int J Cancer. doi: 10.1002\/ijc.28633","journal-title":"Int J Cancer"},{"key":"1608_CR99","doi-asserted-by":"crossref","first-page":"17426","DOI":"10.1073\/pnas.1310522110","volume":"110","author":"PS Rachakonda","year":"2013","unstructured":"Rachakonda PS, Hosen I, de Verdier PJ, Fallah M, Heidenreich B, Ryk C, Wiklund NP, Steineck G, Schadendorf D, Hemminki K, Kumar R (2013) TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism. Proc Natl Acad Sci U S A 110:17426\u201317431. doi: 10.1073\/pnas.1310522110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1608_CR100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.neo.7900004","volume":"1","author":"RD Ramirez","year":"1999","unstructured":"Ramirez RD, D\u2019Atri S, Pagani E, Faraggiana T, Lacal PM, Taylor RS, Shay JW (1999) Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma. Neoplasia 1:42\u201349","journal-title":"Neoplasia"},{"key":"1608_CR101","first-page":"43","volume":"16","author":"JS Reis-Filho","year":"2003","unstructured":"Reis-Filho JS, Preto A, Soares P, Ricardo S, Cameselle-Teijeiro J, Sobrinho-Simoes M (2003) p63 expression in solid cell nests of the thyroid: further evidence for a stem cell origin. Mod Pathol Off J U S Can Acad Pathol Inc 16:43\u201348. doi: 10.1097\/01.MP.0000047306.72278.39","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"1608_CR102","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00401-013-1198-2","volume":"126","author":"M Remke","year":"2013","unstructured":"Remke M, Ramaswamy V, Peacock J, Shih DJ, Koelsche C, Northcott PA, Hill N, Cavalli FM, Kool M, Wang X, Mack SC, Barszczyk M, Morrissy AS, Wu X, Agnihotri S, Luu B, Jones DT, Garzia L, Dubuc AM, Zhukova N, Vanner R, Kros JM, French PJ, Van Meir EG, Vibhakar R, Zitterbart K, Chan JA, Bognar L, Klekner A, Lach B, Jung S, Saad AG, Liau LM, Albrecht S, Zollo M, Cooper MK, Thompson RC, Delattre OO, Bourdeaut F, Doz FF, Garami M, Hauser P, Carlotti CG, Van Meter TE, Massimi L, Fults D, Pomeroy SL, Kumabe T, Ra YS, Leonard JR, Elbabaa SK, Mora J, Rubin JB, Cho YJ, McLendon RE, Bigner DD, Eberhart CG, Fouladi M, Wechsler-Reya RJ, Faria CC, Croul SE, Huang A, Bouffet E, Hawkins CE, Dirks PB, Weiss WA, Schuller U, Pollack IF, Rutkowski S, Meyronet D, Jouvet A, Fevre-Montange M, Jabado N, Perek-Polnik M, Grajkowska WA, Kim SK, Rutka JT, Malkin D, Tabori U, Pfister SM, Korshunov A, von Deimling A, Taylor MD (2013) TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathol 126:917\u2013929. doi: 10.1007\/s00401-013-1198-2","journal-title":"Acta Neuropathol"},{"key":"1608_CR103","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ctrv.2012.06.007","volume":"39","author":"M Ruden","year":"2013","unstructured":"Ruden M, Puri N (2013) Novel anticancer therapeutics targeting telomerase. Cancer Treat Rev 39:444\u2013456. doi: 10.1016\/j.ctrv.2012.06.007","journal-title":"Cancer Treat Rev"},{"key":"1608_CR104","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0002-9440(10)65011-0","volume":"156","author":"P Rudolph","year":"2000","unstructured":"Rudolph P, Schubert C, Tamm S, Heidorn K, Hauschild A, Michalska I, Majewski S, Krupp G, Jablonska S, Parwaresch R (2000) Telomerase activity in melanocytic lesions: a potential marker of tumor biology. Am J Pathol 156:1425\u20131432. doi: 10.1016\/S0002-9440(10)65011-0","journal-title":"Am J Pathol"},{"key":"1608_CR105","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.humpath.2006.12.006","volume":"38","author":"S Saleh","year":"2007","unstructured":"Saleh S, King-Yin Lam A, Gertraud Buettner P, Glasby M, Raasch B, Ho YH (2007) Telomerase activity of basal cell carcinoma in patients living in North Queensland, Australia. Hum Pathol 38:1023\u20131029. doi: 10.1016\/j.humpath.2006.12.006","journal-title":"Hum Pathol"},{"key":"1608_CR106","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/bjc.1998.267","volume":"77","author":"T Sano","year":"1998","unstructured":"Sano T, Asai A, Mishima K, Fujimaki T, Kirino T (1998) Telomerase activity in 144 brain tumours. Br J Cancer 77:1633\u20131637","journal-title":"Br J Cancer"},{"key":"1608_CR107","first-page":"753","volume":"12","author":"SA Savage","year":"2010","unstructured":"Savage SA, Bertuch AA (2010) The genetics and clinical manifestations of telomere biology disorders. Genet Med Off J Am Coll Med Genet 12:753\u2013764. doi: 10.1097\/GIM.0b013e3181f415b5","journal-title":"Genet Med Off J Am Coll Med Genet"},{"key":"1608_CR108","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ajhg.2007.10.004","volume":"82","author":"SA Savage","year":"2008","unstructured":"Savage SA, Giri N, Baerlocher GM, Orr N, Lansdorp PM, Alter BP (2008) TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet 82:501\u2013509. doi: 10.1016\/j.ajhg.2007.10.004","journal-title":"Am J Hum Genet"},{"key":"1608_CR109","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1182\/blood-2011-12-274019","volume":"120","author":"P Scheinberg","year":"2012","unstructured":"Scheinberg P, Young NS (2012) How I treat acquired aplastic anemia. Blood 120:1185\u20131196. doi: 10.1182\/blood-2011-12-274019","journal-title":"Blood"},{"key":"1608_CR110","author":"GA Scott","year":"2013","unstructured":"Scott GA, Laughlin TS, Rothberg PG (2013) Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma. Mod Pathol Off J U S Can Acad Pathol Inc. doi: 10.1038\/modpathol.2013.167","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"1608_CR111","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0959-8049(97)00062-2","volume":"33","author":"JW Shay","year":"1997","unstructured":"Shay JW, Bacchetti S (1997) A survey of telomerase activity in human cancer. Eur J Cancer 33:787\u2013791. doi: 10.1016\/S0959-8049(97)00062-2","journal-title":"Eur J Cancer"},{"key":"1608_CR112","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/ng.407","volume":"41","author":"S Shete","year":"2009","unstructured":"Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, Simon M, Marie Y, Boisselier B, Delattre JY, Hoang-Xuan K, El Hallani S, Idbaih A, Zelenika D, Andersson U, Henriksson R, Bergenheim AT, Feychting M, Lonn S, Ahlbom A, Schramm J, Linnebank M, Hemminki K, Kumar R, Hepworth SJ, Price A, Armstrong G, Liu Y, Gu X, Yu R, Lau C, Schoemaker M, Muir K, Swerdlow A, Lathrop M, Bondy M, Houlston RS (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41:899\u2013904. doi: 10.1038\/ng.407","journal-title":"Nat Genet"},{"key":"1608_CR113","doi-asserted-by":"crossref","first-page":"48","DOI":"10.32607\/20758251-2011-3-1-48-68","volume":"3","author":"DA Skvortsov","year":"2011","unstructured":"Skvortsov DA, Zvereva ME, Shpanchenko OV, Dontsova OA (2011) Assays for detection of telomerase activity. Acta Nat 3:48\u201368","journal-title":"Acta Nat"},{"key":"1608_CR114","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2174\/138920211798120853","volume":"12","author":"P Soares","year":"2011","unstructured":"Soares P, Lima J, Preto A, Castro P, Vinagre J, Celestino R, Couto JP, Prazeres H, Eloy C, Maximo V, Sobrinho-Simoes M (2011) Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas. Curr Genom 12:609\u2013617. doi: 10.2174\/138920211798120853","journal-title":"Curr Genom"},{"key":"1608_CR115","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.bbadis.2009.01.017","volume":"1792","author":"U Svenson","year":"2009","unstructured":"Svenson U, Roos G (2009) Telomere length as a biological marker in malignancy. Biochim Biophys Acta 1792:317\u2013323. doi: 10.1016\/j.bbadis.2009.01.017","journal-title":"Biochim Biophys Acta"},{"key":"1608_CR116","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0092-8674(82)90109-X","volume":"29","author":"JW Szostak","year":"1982","unstructured":"Szostak JW, Blackburn EH (1982) Cloning yeast telomeres on linear plasmid vectors. Cell 29:245\u2013255","journal-title":"Cell"},{"key":"1608_CR117","author":"A Tallet","year":"2013","unstructured":"Tallet A, Nault JC, Renier A, Hysi I, Galateau-Salle F, Cazes A, Copin MC, Hofman P, Andujar P, Le Pimpec-Barthes F, Zucman-Rossi J, Jaurand MC, Jean D (2013) Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma. Oncogene. doi: 10.1038\/onc.2013.351","journal-title":"Oncogene"},{"key":"1608_CR118","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/1523-1747.ep12345811","volume":"106","author":"RS Taylor","year":"1996","unstructured":"Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA, Shay JW (1996) Detection of telomerase activity in malignant and nonmalignant skin conditions. J Investig Dermatol 106:759\u2013765","journal-title":"J Investig Dermatol"},{"key":"1608_CR119","first-page":"370","volume":"57","author":"M Ueda","year":"1997","unstructured":"Ueda M, Ouhtit A, Bito T, Nakazawa K, Lubbe J, Ichihashi M, Yamasaki H, Nakazawa H (1997) Evidence for UV-associated activation of telomerase in human skin. Cancer Res 57:370\u2013374","journal-title":"Cancer Res"},{"key":"1608_CR120","author":"AM Nistelrooij van","year":"2013","unstructured":"van Nistelrooij AM, Zwarthoff EC, Post E, Lurkin I, van Marion R, Kopershoek E, Biermann K, Wijnhoven BP, Dinjens WN (2013) Absence of TERT promoter mutations in esophageal adenocarcinoma. Int J Cancer. doi: 10.1002\/ijc.28527","journal-title":"Int J Cancer"},{"key":"1608_CR121","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/ncomms3185","volume":"4","author":"J Vinagre","year":"2013","unstructured":"Vinagre J, Almeida A, Populo H, Batista R, Lyra J, Pinto V, Coelho R, Celestino R, Prazeres H, Lima L, Melo M, da Rocha AG, Preto A, Castro P, Castro L, Pardal F, Lopes JM, Santos LL, Reis RM, Cameselle-Teijeiro J, Sobrinho-Simoes M, Lima J, Maximo V, Soares P (2013) Frequency of TERT promoter mutations in human cancers. Nat Commun 4:2185. doi: 10.1038\/ncomms3185","journal-title":"Nat Commun"},{"key":"1608_CR122","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1158\/1078-0432.CCR-0620-3","volume":"10","author":"RH Vonderheide","year":"2004","unstructured":"Vonderheide RH, Domchek SM, Schultze JL, George DJ, Hoar KM, Chen DY, Stephans KF, Masutomi K, Loda M, Xia Z, Anderson KS, Hahn WC, Nadler LM (2004) Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes. Clin Cancer Res Off J Am Assoc Cancer Res 10:828\u2013839","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"1608_CR123","doi-asserted-by":"crossref","unstructured":"Wang K, Liu T, Liu L, Liu J, Liu C, Wang C, Ge N, Ren H, Yan K, Hu S, Bjorkholm M, Fan Y, Xu D (2014) TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas. Oncotarget 5:1829\u20131836","DOI":"10.18632\/oncotarget.1829"},{"key":"1608_CR124","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/path.4315","volume":"232","author":"RC Wu","year":"2014","unstructured":"Wu RC, Ayhan A, Maeda D, Kim KR, Clarke BA, Shaw P, Chui MH, Rosen B, Shih Ie M, Wang TL (2014) Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy. J Pathol 232:473\u2013481. doi: 10.1002\/path.4315","journal-title":"J Pathol"},{"key":"1608_CR125","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.eururo.2013.10.038","volume":"65","author":"S Wu","year":"2014","unstructured":"Wu S, Huang P, Li C, Huang Y, Li X, Wang Y, Chen C, Lv Z, Tang A, Sun X, Lu J, Li W, Zhou J, Gui Y, Zhou F, Wang D, Cai Z (2014) Telomerase reverse transcriptase gene promoter mutations help discern the origin of urogenital tumors: a genomic and molecular study. Eur Urol 65:274\u2013277. doi: 10.1016\/j.eururo.2013.10.038","journal-title":"Eur Urol"},{"key":"1608_CR126","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1600-0463.2008.00905.x","volume":"116","author":"CH Yang","year":"2008","unstructured":"Yang CH, Hung WC, Wang SL, Kang WY, Chen WT, Huang YC, Su YC, Chai CY (2008) Immunoexpression and prognostic role of hTERT and cyclin D1 in urothelial carcinoma. APMIS Acta Pathol Microbiol Immunol Scand 116:309\u2013316. doi: 10.1111\/j.1600-0463.2008.00905.x","journal-title":"APMIS Acta Pathol Microbiol Immunol Scand"},{"key":"1608_CR127","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/ijc.27417","volume":"131","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Chen G, Zhao Y, Song X, Chen H, Mao Y, Lu D (2012) Fine-mapping of a region of chromosome 5p15.33 (TERT-CLPTM1L) suggests a novel locus in TERT and a CLPTM1L haplotype are associated with glioma susceptibility in a Chinese population. Int J Cancer 131:1569\u20131576. doi: 10.1002\/ijc.27417","journal-title":"Int J Cancer"},{"key":"1608_CR128","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Gao Y, Chen Z, Hu X, Zhou F, He J (2013) Low frequency of TERT promoter somatic mutation in 313 sporadic esophageal squamous cell carcinomas. Int J Cancer. doi: 10.1002\/ijc.28360","journal-title":"Int J Cancer"},{"key":"1608_CR129","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1039\/c2cs35045a","volume":"41","author":"X Zhou","year":"2012","unstructured":"Zhou X, Xing D (2012) Assays for human telomerase activity: progress and prospects. Chem Soc Rev 41:4643\u20134656. doi: 10.1039\/c2cs35045a","journal-title":"Chem Soc Rev"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-014-1608-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-014-1608-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-014-1608-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T10:54:18Z","timestamp":1689418458000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-014-1608-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,22]]},"references-count":129,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["1608"],"URL":"https:\/\/doi.org\/10.1007\/s00428-014-1608-4","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,22]]}}}